Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination
The distribution of the novel Covid-19 vaccines has been on a scale as unprecedented as the pandemic itself. While the vaccines promise to greatly reduce the spread and impact of the disease, encountering side-effects in clinical practice may pose diagnostic dilemmas. In this case report, we describ...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194501/ https://www.ncbi.nlm.nih.gov/pubmed/34149984 http://dx.doi.org/10.1016/j.radcr.2021.05.031 |
_version_ | 1783706423203463168 |
---|---|
author | Aalberg, Jeffrey J Collins, Timothy P Dobrow, Ethan M |
author_facet | Aalberg, Jeffrey J Collins, Timothy P Dobrow, Ethan M |
author_sort | Aalberg, Jeffrey J |
collection | PubMed |
description | The distribution of the novel Covid-19 vaccines has been on a scale as unprecedented as the pandemic itself. While the vaccines promise to greatly reduce the spread and impact of the disease, encountering side-effects in clinical practice may pose diagnostic dilemmas. In this case report, we describe a patient with known metastatic renal cell carcinoma who presents with axillary lymphadenopathy found on PET/CT imaging after receiving a Covid-19 vaccine, which was subsequently confirmed to be reactive lymphadenopathy following biopsy. |
format | Online Article Text |
id | pubmed-8194501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81945012021-06-15 Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination Aalberg, Jeffrey J Collins, Timothy P Dobrow, Ethan M Radiol Case Rep Case Report The distribution of the novel Covid-19 vaccines has been on a scale as unprecedented as the pandemic itself. While the vaccines promise to greatly reduce the spread and impact of the disease, encountering side-effects in clinical practice may pose diagnostic dilemmas. In this case report, we describe a patient with known metastatic renal cell carcinoma who presents with axillary lymphadenopathy found on PET/CT imaging after receiving a Covid-19 vaccine, which was subsequently confirmed to be reactive lymphadenopathy following biopsy. Elsevier 2021-06-11 /pmc/articles/PMC8194501/ /pubmed/34149984 http://dx.doi.org/10.1016/j.radcr.2021.05.031 Text en © 2021 Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Aalberg, Jeffrey J Collins, Timothy P Dobrow, Ethan M Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination |
title | Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination |
title_full | Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination |
title_fullStr | Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination |
title_full_unstemmed | Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination |
title_short | Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination |
title_sort | axillary lymphadenopathy in a renal cell carcinoma patient after covid-19 vaccination |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194501/ https://www.ncbi.nlm.nih.gov/pubmed/34149984 http://dx.doi.org/10.1016/j.radcr.2021.05.031 |
work_keys_str_mv | AT aalbergjeffreyj axillarylymphadenopathyinarenalcellcarcinomapatientaftercovid19vaccination AT collinstimothyp axillarylymphadenopathyinarenalcellcarcinomapatientaftercovid19vaccination AT dobrowethanm axillarylymphadenopathyinarenalcellcarcinomapatientaftercovid19vaccination |